Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and caffeic acid

angiotensin ii has been researched along with caffeic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alajarín, R; Alvarez-Builla, J; Díez-Marqués, ML; García, G; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Serrano, I; Vaquero, JJ1
Kojima, I; Kojima, K; Rasmussen, H1
Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Mitani, T; Xu, JW; Yamori, Y1
Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y1
Du, CX; Huang, CW; Ku, HC; Kuo, YH; Lee, SY1

Other Studies

5 other study(ies) available for angiotensin ii and caffeic acid

ArticleYear
New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
    European journal of medicinal chemistry, 2012, Volume: 50

    Topics: Amides; Amines; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Caffeic Acids; Cells, Cultured; Esters; Hypertension; Losartan; Male; Molecular Structure; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Structure-Activity Relationship; Vasoconstrictor Agents

2012
Possible role of phospholipase A2 action and arachidonic acid metabolism in angiotensin II-mediated aldosterone secretion.
    Endocrinology, 1985, Volume: 117, Issue:3

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Acetophenones; Aldosterone; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Caffeic Acids; Calcium; Cattle; Cyclooxygenase Inhibitors; Dantrolene; Dose-Response Relationship, Drug; Indomethacin; Lipoxygenase Inhibitors; Phospholipases; Phospholipases A; Phospholipases A2; Pyrazoles; Quinacrine

1985
Downregulation of Rac1 activation by caffeic acid in aortic smooth muscle cells.
    Life sciences, 2005, Apr-29, Volume: 76, Issue:24

    Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Aorta; Blotting, Western; Caffeic Acids; Cycloheximide; Enzyme Activation; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Male; Muscle, Smooth, Vascular; Neoplasm Proteins; p21-Activated Kinases; Phosphorylation; Protein Serine-Threonine Kinases; rac1 GTP-Binding Protein; Rats; Rats, Inbred WKY; Superoxides; Transfection

2005
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:4

    Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents

2005
A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 162

    Topics: Angiotensin II; Animals; Caffeic Acids; Cardiomyopathies; Collagen; Fibroblasts; Fibrosis; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling

2023